KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Net Income towards Common Stockholders: 2017-2025

Historic Net Income towards Common Stockholders for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to -$77.7 million.

  • Twist Bioscience's Net Income towards Common Stockholders rose 21.79% to -$27.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$77.7 million, marking a year-over-year increase of 62.79%. This contributed to the annual value of -$77.7 million for FY2025, which is 62.80% up from last year.
  • Per Twist Bioscience's latest filing, its Net Income towards Common Stockholders stood at -$77.7 million for FY2025, which was up 62.80% from -$208.8 million recorded in FY2024.
  • Twist Bioscience's Net Income towards Common Stockholders' 5-year high stood at -$77.7 million during FY2025, with a 5-year trough of -$217.9 million in FY2022.
  • In the last 3 years, Twist Bioscience's Net Income towards Common Stockholders had a median value of -$204.7 million in 2023 and averaged -$163.7 million.
  • As far as peak fluctuations go, Twist Bioscience's Net Income towards Common Stockholders slumped by 43.24% in 2022, and later surged by 62.80% in 2025.
  • Twist Bioscience's Net Income towards Common Stockholders (Yearly) stood at -$152.1 million in 2021, then slumped by 43.24% to -$217.9 million in 2022, then increased by 6.06% to -$204.7 million in 2023, then decreased by 2.00% to -$208.8 million in 2024, then soared by 62.80% to -$77.7 million in 2025.